FibroGen Inc
NASDAQ:KYNB
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
FibroGen Inc
NASDAQ:KYNB
|
US |
|
F
|
First Citizens BancShares Inc (Delaware)
F:FC6A
|
US |
|
Dufry AG
F:D2J
|
CH |
|
A
|
Ascendis Pharma A/S
F:A71
|
DK |
|
V
|
Vinci SA
SWB:SQU
|
FR |
|
C
|
CME Group Inc
F:MX4A
|
US |
|
Delta Electronics Thailand PCL
SET:DELTA
|
TH |
|
H
|
Healthcare Services Group Inc
F:HS1
|
US |
|
L
|
Linamar Corp
OTC:LIMAF
|
CA |
|
M
|
Mosaic Co
XMUN:02M
|
US |
|
C
|
Cooper-Standard Holdings Inc
F:C31
|
US |
|
Imperial Oil Ltd
TSX:IMO
|
CA |
Intrinsic Value
The intrinsic value for 
FibroGen Inc (KYNB) under the Base Case is hidden
USD.
Compared with the current market price of 6.69 USD, the stock appears hidden
.
KYNB looks undervalued. But is it really? Some stocks live permanently below intrinsic value; one glance at Historical Valuation reveals if KYNB is one of them.
Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.
Let our AI break down the key assumptions behind the intrinsic value calculation for FibroGen Inc.
Fundamental Analysis
Revenue & Expenses Breakdown
FibroGen Inc
Earnings Waterfall
FibroGen Inc
The intrinsic value for FibroGen Inc (KYNB) under the Base Case is hidden USD.
Compared with the current market price of 6.69 USD, the stock appears hidden.
